FDA Warns of Unapproved, Misbranded Drugs Distributed by CanaRx to US Consumers
The Food and Drug Administration (FDA) has issued a warning letter to CanaRx, a company operating as a prescription drug provider, for its involvement in the distribution of certain unapproved or misbranded drugs that may be harmful to US consumers.
